First Implant in the Kingdom of Saudi Arabia – Continued Global Growth for Impulse Dynamics’ Optimizer IVs Device.
Stuttgart, Germany – August 23rd, 2015 – Impulse Dynamics announced today (23 August, 2015) the first implantation of its Optimizer IVs device in the Kingdom of Saudi Arabia, at the King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Riyadh. The implantation was performed by Dr. Bandar Al Ghamdi. The CCM team at KFSH&RC includes Dr. Jehad Al Buraiki, Heart Centre Director, Dr. Majid Al Fayyadh, Heart Centre Deputy Director, Dr. Azam Shafquat, Consultant cardiologist/ electrophysiologist and Dr. Bandar Al Ghamdi, Consultant cardiologist/ electrophysiologist.
The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF), a growing public health problem in Saudi Arabia. “We are happy to have the Optimizer system which gives a new therapeutic option and hope to our heart failure patients in Saudi Arabia” commented Dr. Al Ghamdi. The Optimizer system is based on the novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses to the heart. “This therapy will address those patients with symptomatic heart failure and narrow QRS complex despite pharmacological therapy for whom there is no other device based option” Dr. Al Ghamdi continued.
“These implants are a significant milestone in our continued commercial expansion” said Dr. Simos Kedikoglou, CEO of Impulse Dynamics. “CCM is a well-established technology that meets a major need globally, and we plan to further expand its introduction in Saudi Arabia and other Middle Eastern countries to benefit more patients with heart failure.“
About the Optimizer and CCM Therapy
CCM is the brand name for Cardiac Contractility Modulation, the non-excitatory electrical pulses delivered by the implantable Optimizer device during the absolute refractory period of the heart’s cardiac cycle to improve systolic contraction of the heart. The Optimizer System has been implanted in over 4,000 patients and is currently available in the US, Europe, China, Brazil, India, and more than 40 other countries around the world. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and the results have been published in over 80 articles appearing in leading medical journals.
About Impulse Dynamics
Impulse Dynamics is a medical device company dedicated to transforming the treatment of chronic heart failure. With global headquarters in Mount Laurel, N.J., the company has additional offices in; Stuttgart, Germany, Orangeburg, N.Y. and Curacao For more information please visit www.impulse-dynamics.com.
Impulse Dynamics (USA), Inc.
523 Fellowship Road, Suite 203
Mt. Laurel, NJ 08054